跳至主要内容
临床试验/EUCTR2021-000401-24-BE
EUCTR2021-000401-24-BE进行中(未招募)1 期

Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection (PICOV) A Non-commercial multicentre academic prospective cohort study in nursing home staff and residents during the winter season 2020-2021 and 2021-2022 - PICOV

Sciensano0 个研究点目标入组 300 人开始时间: 2021年1月26日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Sciensano
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Being enrolled and participating in the PICOV 2 study.
  • -Having previously received two doses of BNT162b2 COVID-19 mRNA vaccine (Comirnaty).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 110
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 110

排除标准

  • -Pregnancy.
  • -Having previously received one or more doses of a commercially available COVID-19 vaccine other than BNT162b2 (Comirnaty).
  • -Having participated in any other phase 1/2/3 clinical trial where a COVID-19 vaccine candidate has been administered.

研究者

发起方
Sciensano

相似试验